AU2015234306B2 - Tfpi inhibitors and methods of use - Google Patents

Tfpi inhibitors and methods of use

Info

Publication number
AU2015234306B2
AU2015234306B2 AU2015234306A AU2015234306A AU2015234306B2 AU 2015234306 B2 AU2015234306 B2 AU 2015234306B2 AU 2015234306 A AU2015234306 A AU 2015234306A AU 2015234306 A AU2015234306 A AU 2015234306A AU 2015234306 B2 AU2015234306 B2 AU 2015234306B2
Authority
AU
Australia
Prior art keywords
methods
tfpi inhibitors
tfpi
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2015234306A
Other versions
AU2015234306A1 (en
Inventor
Michael Dockal
Hartmut Ehrlich
Thomas Polakowski
Ulf Reimer
Ulrich Reineke
Friedrich Scheiflinger
Eberhard Schneider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009327338A external-priority patent/AU2009327338B2/en
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Priority to AU2015234306A priority Critical patent/AU2015234306B2/en
Publication of AU2015234306A1 publication Critical patent/AU2015234306A1/en
Application granted granted Critical
Publication of AU2015234306B2 publication Critical patent/AU2015234306B2/en
Assigned to Baxalta GmbH, BAXALTA INCORPORATED reassignment Baxalta GmbH Request for Assignment Assignors: BAXTER HEALTHCARE SA, BAXTER INTERNATIONAL INC.
Priority to AU2017203999A priority patent/AU2017203999B2/en
Assigned to TAKEDA PHARMACEUTICAL COMPANY LIMITED reassignment TAKEDA PHARMACEUTICAL COMPANY LIMITED Request for Assignment Assignors: Baxalta GmbH, BAXALTA INCORPORATED
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

AU2015234306A 2008-12-19 2015-09-30 Tfpi inhibitors and methods of use Active AU2015234306B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2015234306A AU2015234306B2 (en) 2008-12-19 2015-09-30 Tfpi inhibitors and methods of use
AU2017203999A AU2017203999B2 (en) 2008-12-19 2017-06-14 Tfpi inhibitors and methods of use

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61/139,272 2008-12-19
AU2009327338A AU2009327338B2 (en) 2008-12-19 2009-12-21 TFPI inhibitors and methods of use
AU2015234306A AU2015234306B2 (en) 2008-12-19 2015-09-30 Tfpi inhibitors and methods of use

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2009327338A Division AU2009327338B2 (en) 2008-12-19 2009-12-21 TFPI inhibitors and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2017203999A Division AU2017203999B2 (en) 2008-12-19 2017-06-14 Tfpi inhibitors and methods of use

Publications (2)

Publication Number Publication Date
AU2015234306A1 AU2015234306A1 (en) 2015-10-22
AU2015234306B2 true AU2015234306B2 (en) 2017-04-20

Family

ID=

Similar Documents

Publication Publication Date Title
HRP20192282T8 (en) Tfpi inhibitors and methods of use
HK1254895A1 (en) Benzylbenzene derivatives and methods of use
EP3153023B8 (en) Benzoxazole kinase inhibitors and methods of use
AU2009221838A8 (en) Implants and methods of use
HK1160119A1 (en) Kinase inhibitors and methods of use
EP2252293A4 (en) Kinase inhibitors and methods of use
HK1147254A1 (en) 5-anilinoimidazopyridines and methods of use 5-
HK1172896A1 (en) Compounds and methods of use
HK1161094A1 (en) Compounds and methods of use
HK1162352A1 (en) Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof -3-
HK1149933A1 (en) Diazacarbazoles and methods of use
IL209548A0 (en) Diazacarbazoles and methods of use
IL206125A0 (en) Azaindolizines and methods of use
EP2344204A4 (en) Telomerase inhibitors and methods of use thereof
WO2009155116A9 (en) Methods of reducing pain and inflammation
IL206891A0 (en) Therapeutic inhibitors of pai-1 function and methods of their use
EP2126056A4 (en) Paramyxovirus family inhibitors and methods of use thereof
EP2242367A4 (en) Rel inhibitors and methods of use thereof
EP2381779A4 (en) Selective inhibitors of akt and methods of using same
AU2015234306B2 (en) Tfpi inhibitors and methods of use
AU2008903571A0 (en) Device and method of use
AU2007905434A0 (en) Arsenoxide compound and method of use
AU2007906750A0 (en) Micro-identifiers and methods of application thereof
AU2006907075A0 (en) Compounds and Methods of Use
AU2008905077A0 (en) Antioxidant compounds and methods of their use